Posted by Michael Wonder on 02 Aug 2023
Ganaxolone for the treatment of patients with seizures caused by CDKL5 deficiency disorder
2 August 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use of ganaxolone in the NHS in England.
Ganaxolone is not recommended as an add-on treatment option for children and adolescents aged 2 to 17 years and adults who turn 18 while on treatment with seizures caused by cyclin-dependent kinase-like 5 deficiency disorder.
